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A collaborative study to determine what role, if any, vitamin D3 plays in the survival of a 
zooplankton genus, Daphnia (spp.), under the stress of UV radiation is currently ongoing.  The 
portion of the study described here is a method towards linking vitamin D3 to a fluorophore (Nile 
Blue A).  Functionalization and linking of Nile Blue A and vitamin D3 is explored utilizing 
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Over the past few decades there has been growing concern due to the presence of two 
holes in the ozone layer over each of the Arctic and A tarctic regions1.  The destruction of ozone 
in the stratosphere is dominated by the catalytic rea tion of nitrogen, hydrogen, chlorine, and 
bromine oxides by green house gases2.   
The effects of decreased ozone include increased concentrations of ultraviolet radiation 
(UVR) reaching the Earth’s surface.  The UVR can be broken down into three different types, 
based on wavelength of radiation: UVA, 400-320nm; UVB, 320-290nm; and UVC, 290-200nm.3  
Longer wavelengths are required for vision in animals and photosynthesis in plants, while shorter 
wavelength UVB radiation is damaging to living organisms (through DNA damage), and even 
shorter wavelength UVC radiation is instant cell death.  Ozone absorbs most of the solar UVB 
radiation, in addition to UVC and some UVA.  However with the thinning of the stratospheric 
ozone an increasing percentage of UVB radiation at Ear h’s surface has been detected4. 
In humans, UV radiation damages the DNA, and vitamin D3 (1) is utilized in the repair 
mechanism for that UV damage5.  Vitamin D3 (1) can act as a secondary target for UVR rather 
than DNA undergoing more damage6.  There are also thoughts that vitamin D3 (1) has the 
potential to increase repair rates.  The purpose of this collaborative research is to determine how 
freshwater systems are affected by the increased UVR.  In order to do that daphnia are studied, in 





Figure 1: Molecular structure of vitamin D3 (1) 
2 
In order to study the effects of the increased UVR, freshwater zooplankton, specifically 
daphnia (Figure 2), were chosen.  Daphnia are an excell nt model because they are primary 
consumers and they have a significant effect as a food source on their environment4.  They are the 
base of many freshwater food webs, so scientists can extrapolate the survival and reproductive 
effects of the daphnia to the rest of the food web.  Daphnia are an excellent organism to study for 
multiple reasons.  Daphnia are highly sensitive to nvironmental stressors such as UV radiation7.  
Daphnia are readily available in freshwater environme ts, they are common in clear lake systems, 
and easily maintained in a laboratory setting.  Also, proper assessment of their reproduction and 
survival is well known, they are sometimes transparent, and they are parthenogenic (clonal 
organisms with females giving rise to females).  Without sexual reproduction, the genome of the 
daphnia changes very little from generation to generation.  This allows for the study of essentially 
the same organism over many months without having to consider individual variations of any 
adaptive mechanisms. 
 
Figure 2: Picture of Daphnia pulicaria8 
3 
This research is the result of a collaboration betwe n Dr. Sandra Connelly, Dr. Loraine 
Tan, and Dr. Jeremy Cody.  The goal of the collaborti n is to study the uptake of vitamin D3 (1) 
in daphnia.  For each aspect of these studies it takes some overlap between the different 
specialties of organic chemistry, biology and analytical chemistry (Figure 3).   
 
Figure 3: Diagram of overlapping skill sets 
1.1 Overall goals 
The goal of the collaboration is to investigate the potential benefits of vitamin D3 (1) 
metabolites as a protective mechanism against ultraviolet radiation exposure.  This is 
accomplished by exposing the daphnia to vitamin D3 (1), allowing them to metabolize the 
compound, and then isolating the organic metabolites.  Also, the survival rates are studied by 
exposing daphnia to vitamin D3 (1) and exposing them to UVR and monitoring their survival over 
time. Another goal of the collaboration is to determine where in the body of the daphnia vitamin 
D3 (1) is being sequestered.  In order for this last goal to be accomplished, the Cody group in 
addition to the Tan group is utilized by linking a fluorophore to vitamin D3 (1) and determining 
where it is located in the body of the daphnia using a fluorescent microscope.  Distinguishing the 
location of vitamin D3 (1) in the daphnia is important for identifying which organs or tissues may 









1.2 Cody group goals 
The goal of the Cody group is to design and prepare a compound that allows for the 
visualization of vitamin D3 (1) while it is in the body of the daphnia.  Vitamin D3 (1) is not 
colored nor does it fluoresce, so in order to see it, one approach is to add on a fluorescent group to 
vitamin D3 (1).  Another goal of the Cody group is to isolate thorganic metabolites of vitamin 
D3 (1) (along with the Tan lab) and analyze them via various instrumentation techniques.   
2. Isolation of organic metabolites of vitamin D3
 (1) 
In the human body there is a pathway in which vitamn D3 (1) is made and metabolized.  
As seen in Scheme 1, the body contains 7-dehydrocholesterol (2) in the dermis layer of the skin.  
There, the 7-dehydrocholesterol (2) is photolyzed by ultraviolet irradiation.  The photolyzation 
leads to previtamin D3 (3) which then spontaneously isomerizes to vitamin D3 (1).  Vitamin D3 
(1) is then transported to the liver via the blood where it is hydroxylated to 25-hydroxyvitamin D3 
(4).  25-Hydroxyvitamin D3 (4) is further metabolized in the kidneys to 1α,25-dihydroxyvitamin 
D3 (5).  The final metabolite is then transported via the plasma to target cells located in the 



























1a,25-Dihydroxyvitamin D3 (5)  
Scheme 1 : Metabolic pathway of vitamin D3 (1) in humans 
5 
Part of the research involves determining which metabolites of vitamin D3 (1) are made 
by daphnia.  The goal of this part of the research involves determining if the daphnia are ingesting 
and metabolizing the vitamin D3 (1) into any recognizable metabolites.  In order to accomplish 




































Figure 4: Set up of biological experiments10 
Six 50mL centrifuge tubes were set up with varying amounts of vitamin D3 (1), a 
constant concentration of green algae food, and daphni  or no daphnia.  The setup (both daphnia 
and no daphnia) were incubated for 72 hours at 20°C on a light cycle of 16:8, (light: dark, UVA: 
dark; 103 kJ/m2 total UVA).  After 72 hours, the daphnia, lgae and synthetic freshwater were 
separated10.  The organic metabolites were then extracted using ethyl acetate.  The resulting 
solutions were analyzed using HPLC to determine the amount of vitamin D3 (1) and its 
metabolites that were isolated.  Both vitamin D3 (1) and 25-hydroxyvitamin D3 (4) were then 
quantified by Dr. Tan’s group11. 
3. Thesis goals 
The goal of this thesis is to link a fluorophore to vitamin D3 (1).  This is accomplished in 
two ways.  The first approach includes coupling a fluorophore onto vitamin D3 (1), exposing 
6 
daphnia to the compound, then using a fluorescent microscope to visualize where in the daphnia’s 
body vitamin D3 (1) is sequestered (Figure 5).  
 
 
Figure 5: Pictorial representation of approach A (linking befor  ingestion) 
The second approach involved creating a minitag on vitamin D3 (1), exposing the compound to 
daphnia then saturating the daphnia with the corresponding minitagged fluorophore (Figure 6).  
The theory is that the two compounds would link in the body where vitamin D3 (1) had been 

































Figure 6: Pictorial representation of approach B (linking after ingestion) 
3.1 Linking vitamin D 3 (1) to the fluorophore before ingestion (approach A) 
Approach A (linking before ingestion) of this project is the first approach investigated.  
There are both positive and negative aspects to this approach.  One positive aspect is the ability to 
synthesize the linked species of vitamin D3 (1) and a fluorophore, in a laboratory setting under 
controlled situations.  A negative aspect is that we do not know whether or not the daphnia are 



































When linked, as in Figure 7, the fluorophore may interfere with the active sites on 









Figure 7: Molecular structure of Nile Blue A (12) linked to vitamin D3 (1) (6) 
The first hydroxylation occurs at C-25 which is on the opposite side of the molecule from 
where the fluorophore is being linked (Figure 8).  So the formation of 25-hydroxyvitamin D3 (4) 
is not the concern; the second hydroxylation occurs at C-1 which is 2 carbons away from where 
the fluorophore is to be linked.  This means if daphnia are converting to 1α,25-dihydroxyvitamin 
D3 (5) the fluorophore might get in the way of the metabolism.  The overall size of the linked 
species (6) is twice the size of vitamin D3 (1) which can interfere with the absorption capabilities 
of daphnia.  Also, the linking adjusted the polarity of vitamin D3 (1).  Adding in a fluorophore 


















Figure 8: Molecular structure of 25-hydroxyvitamin D3 (4) 
3.1.1 Initial fluorophore selection 
Initially Texas Red sulfonyl chloride (TRSC) (7) (Figure 9) was chosen as the 
fluorophore.  It is a fluorescent dye with an excitation wavelength of 594nm and an emission 
9 
wavelength of 623nm while in ethanol13.  The wavelengths fall into the wavelength range ne ded 
for the fluorescent microscope that is available to us.  Also, the emission wavelength does not 
overlap with the fluorescence wavelength of the algae that are fed to the daphnia.  TRSC (7) also 











Figure 9: Molecular structure of Texas Red sulfonyl chloride (7) 
3.1.2 Sulfonamide bond formation with vitamin D3 (1) 
Vitamin D3 (1) must first be functionalized to amine 10 in order to link to TRSC (7).  
This functionalization was done using a known procedur 14.  First a 1,4-addition was performed 
to add acrylonitrile (9) to vitamin D3 (1) to form nitrile 9.  Nitrile 9 was then reduced to amine 10 
using lithium aluminum hydride in diethyl ether (Scheme 2).  There was a very poor isolation of 
























Scheme 2: Preparation of vitamin D3 amine 10 
If amine 10 was readily available in our hands, then it would have been linked to TRSC 


























7 1110  
Scheme 3: Proposed coupling of vitamin D3 amine 10 to TRSC (7) 
The synthesis was abandoned for multiple reasons.  O e reason was the inability to 
isolate amine 10 effectively. Another reason is, TRSC (7) is a very expensive fluorophore. Also, 
the method described in Schemes 2 and 3 cannot be utiliz d in satisfying approach B (linking 
after ingestion).  Lastly commercial TRSC (7) has various isomers, resulting in the undesired 
generation of disubstituted products.  These disubstit ted products have been seen to form from 
TRSC (7) having two sulfonyl chloride groups.  After coupling TRSC (7) with a model amine, 
11 
diadditions were observed as a significant by-product. Therefore an alternate fluorophore was 
investigated. 
3.1.3 Final fluorophore selection 
The next fluorophore that was studied was Nile Blue A (12) (Figure 10).  Nile Blue A 
(12) is a fluorescent dye with an absorption wavelength at 626nm and an emission wavelength of 
668nm (in methanol)15.  Once again the emission wavelength does not overlap with the 
fluorescence wavelength of the algae.  Nile Blue A (12) has an amine rather than a sulfonyl 
chloride functionality necessitating a different type of chemistry to allow for coupling.  An added 
benefit to Nile Blue A (12) is it is less expensive ($62.70/25g)16 than TRSC (7) ($103/5mg)17. 













Figure 10: Molecular structure of Nile Blue A (12) 
In order to link the new fluorophore to vitamin D3 (1) different coupling strategies were 
utilized.   
3.1.4 Carbonyl diimidazole coupling  
In order to link vitamin D3 (1) and Nile Blue A (12), carbonyldiimidazole (CDI) coupling 




















CDI, 0.05 equiv DMAP
DMF
 
Scheme 4: CDI coupling between vitamin D3 (1) and Nile Blue A (12) 
The CDI reaction forms a carbamate bond between an ami e and an alcohol in two steps.  The 
first step is adding the imidazole ring to the alcohol, then to link that isolatable intermediate with 
the amine to form the carbamate bond.   
3.1.4.1 Model system to develop CDI coupling 
Prior to starting to work with vitamin D3 (1) and Nile Blue A (12), model systems were 
studied.  A model system allows for optimization of reaction conditions without using expensive 
and unstable materials.  Nile Blue A (12) and vitamin D3 (1) are unstable due to the light and heat 
sensitive nature of the compounds.  The models utilized are seen in Figure 11.  Cyclohexanol (13) 
was chosen as the model for vitamin D3 (1) due to both being a secondary alcohol and on a 
cyclohexane ring.  Aniline (14) was chosen to model Nile Blue A (12) since it bears both an 
aromatic ring and an amine. 
OH NH2
13 14  
Figure 11: Cyclohexanol (13) and aniline (14) as models for vitamin D3 (1) and Nile Blue A 
(12), respectively 
The first attempt at this reaction was completed following the one-pot two-step literature 
conditions from Rannard and Davis18 (Scheme 5).  One equivalent of cyclohexanol (13) was 
dissolved in toluene under argon at 60°C.  One equivalent of aniline was then added along with 
13 
0.05 eq. KOH.  The solution was allowed to react for 2 hours, and then 1.5 eq. aniline was added 











Scheme 5: CDI coupling of 13 and 14 to form carbamate 15 
The reaction performed by Rannard and Davis had a secondary alcohol interacting with 
an aliphatic primary amine (Scheme 6).  Amine 17 produces high yields18 under these conditions 
whereas amine 14 does not produce any of carbamate 15. Our model reaction may not have 









Scheme 6: Literature model reaction 
Since the one-pot two-step procedure did not form any of carbamate 15, both steps were 
explored individually.   The first step, formation f the imidazole intermediate, was optimized 
using the conditions described in Table 119.
None of the reactions required purification because the crude product was deemed pure 
enough to continue via 1H NMR (Figure 12). The run using DCM and DMAP (Table 1, Entry 3), 
was chosen as the optimal conditions for the first half of the reaction due to the conditions 















13 19 20  
Entry Conditions Yield (crude) 
1 1 eq. CDI, DCM, KOH, 40°C, 19hr 33% 
2 1 eq. CDI, THF, DMAP, 48°C, 4hr 84% 
3 1 eq. CDI, DCM, DMAP, 40°C, 4hr 90% 
 
   
Figure 12: 1H NMR (CDCl3) of cyclohexanol imidazole 20 
The optimized reaction conditions were then utilized to prepare imidazole intermediate 
21 from vitamin D3 (1), as seen in Scheme 7, in a 75% crude yield.   Vitamin D3 imidazole 21 has 
been seen to degrade over time necessitating purification using silica gel column chromatography 
if stored.   


























 DCM, reflux, 3hr
75% crude yield
 
Scheme 7: Formation of vitamin D3 imidazole 21 
The second half of the CDI coupling reaction involved reacting cyclohexanol imidazole 
20 with aniline (14).  As seen in Table 2, multiple conditions were investigated until the optimal 
conditions, with the greatest percent conversion, were found.  In the first five reactions no product 
was detected via 1H NMR or LRMS (Table 2, entries 1-5).  When aniline was used as the solvent 
the desired product was observed (Table 2, entry 6)19.  














1 Toluene, 60°C, 5 hr >100% 0% 
2 Toluene, 60°C, 1.5 eq aniline, 71 hr 55% 0% 
3 Toluene, 60°C, 0.1 eq DMAP, 28 hr 46% 0% 
4 DCM, 40°C, 0.1 eq DMAP, 28 hr 76% 0% 
5 DCM, 60°C, 0.1 eq DMAP, high pressure, 6 hr 36% 0% 
6 DMAP, aniline as solvent, 40-103.3°C, 98.5 hr 41% >95% (32%) 
7 DMAP, 60°C, aniline as solvent, 73 hr >100% >95% 
8 DMAP, 80°C, aniline as olvent, 73 hr >100% >95% 
9 DMAP, DMF, 60°C, 72 hr >100% 40% 
10 DMAP, DMSO, 60°C, 72 hr >100% 49% 
 
To access the effectiveness of the reaction conditis the percent conversion was 
calculated via 1H NMR by monitoring at the peak of the tertiary proton on cyclohexanol (letter A 
16 
in Figure 13).  When the reaction did not go to completion there were two tertiary proton peaks 
allowing for the calculation of a conversion percentage. 
 
Figure 13: 1H NMR (CDCl3) of carbamate 15 
Once the reaction proceeded, the temperature was optimized19.  Both reactions (Table 2, 
entries 7 & 8) worked affording the same percent coversion.  The lower temperature (60°C vs. 
80°C) was used (Table 2, Entry 7 and 8), since vitamin D3 (1) degrades in heat.  Lastly, the 
solvent was optimized19.  Nile Blue A (12) is a solid which means, unlike aniline, it cannot act as 
the solvent of a reaction, so DMSO and DMF were tried.  Both solvents dissolve Nile Blue A (12) 
and were shown to be effective for the reaction (see entries 9 and 10). 
Once the optimal conditions were identified, the coupling of Nile Blue A (12) to 
cyclohexanol imidazole 20 was explored.  The reaction was taken in a stepwise fa hion as with 
the model system.  The reaction in Scheme 8 was performed once in DMF and once in DMSO 
both with 0.01 eq DMAP, and 5 eq. of Nile Blue A (12).  The reaction stirred at 60°C for 288 h 
under argon, meanwhile being monitored by LRMS.  The product mass was observed during the 
reaction.  When running with DMF there was a >100% mass recovery after extracting with 
dichloromethane.  The product appeared to contain residual DMF, so a second extraction with 







during the work up.  A UV light (short wavelength) was shown on the layers and the organic 
layer fluoresced whereas the aqueous layer did not.  After the second work up, the mass recovery 
was 8%.  The product was not observed ia 1H NMR.   
The same reaction was repeated using DMSO and extracted with dichloromethane.  The 
product was observed with LRMS but was not observed with 1H NMR.  The lack of detection in 
1H NMR could be because there was not an appreciable yield of product.  The LRMS is 

















Scheme 8: Coupling of Nile Blue A (12) with cyclohexanol imidazole 20 
Finally, CDI coupling was applied to the Nile Blue A (12), vitamin D3 (1) system.  The 
LRMS for Scheme 8 data did show the MW product peak m ing us optimistic that the real 
system would work.  There are two routes to couple vitamin D3 (1) to Nile Blue A (12) using CDI 
coupling.  First CDI can be reacted with vitamin D3 (1) to form vitamin D3 imidazole 21 then the 
resulting compound can be coupled to Nile Blue A (12).  The other route is to add CDI into Nile 


























Scheme 9: Formation of Nile Blue A/vitamin D3 carbamate 6 via vitamin D3 imidazole 21 
18 
It was predicted Nile Blue A (12) would link with vitamin D3 imidazole 21 as seen in 
Scheme 9.  Initially, 21 was reacted with Nile Blue A (12) in the presence of DMF and 0.05eq 
DMAP.  Only starting material 21 was observed after 168 h of monitoring via LRMS.  Since the 
sequence of adding CDI to vitamin D3 (1) first did not work, CDI was reacted with Nile Blue A 
(12) prior to coupling to vitamin D3 (1).  It was thought that vitamin D3 (1) is a better nucleophile 
than Nile Blue A (12) and the addition would be more effective with the better nucleophile added 
















Scheme 10: Formation of Nile Blue A imidazole 23 
When Nile Blue A (12) was stirred with 1.1 equivalents CDI (19) in the presence of 
DMAP (0.05 eq.) in DMF at 40°C for 4 days (Scheme 10), formation of 23 was observed via 
LRMS.  A m/z peak was present at 376 for Nile Blue A/ methanol adduct 24.  The 376 m/z may 


















m/z = 376  
Scheme 11: Methanol adding into Nile Blue A imidazole 23 to form Nile Blue A/methanol 
adduct 24 
Isolation of imidazole 23 is very difficult.  To work up the reaction an extraction was 
performed using dichloromethane, and similar to the coupling in Scheme 8, there was poor 
19 
separation between the aqueous layer and organic layer.  Attempts to work up this reaction lead to 
entire loss of Nile Blue A imidazole 23.  Therefore, the CDI coupling with Nile Blue A (12) was 
completed as a one-pot two-step reaction. 
The one-pot two-step coupling of Nile Blue A (12) and vitamin D3 (1) was performed as 
seen in Scheme 4 (and Table 3).  The reaction was performed with CDI, 0.05eq DMAP, and 
DMF.  The temperature varied from 40°C to 85°C and the length of the reaction varied from 25 h 
to 216 h as seen in Table 3.  When monitoring v a LRMS Nile Blue A imidazole 23 is assumed to 
be forming due to the presence of the 376 m/z peak (Nile Blue A/methanol adduct 24, Scheme 
11), however Nile Blue A imidazole 23 was not observed via 1H NMR.  The final product 6 was 
visualized also via LRMS but again was not visible via 1H NMR.  Therefore it was assumed that 
the reaction did occur, just not in an appreciable yield. 


















CDI, 0.05 equiv DMAP
DMF
 
Entry Eq. of 1 Temperature Duration 
1 1 40°C 191hr 
2 1 80°C 96hr 
3 1 85°C 25hr 
4 3 60°C 146hr 
5 3 40°C 216hr 
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A novel work up for this reaction was discovered that may be effective for other Nile 
Blue A (12) coupling reactions.  Rather than attempting to extract with an organic solvent (which 
leads to an inability to distinguish between organic and aqueous layers and the development of 
rag layers), adding in an aqueous wash precipitated he product out.  The reaction was diluted in 
20mL 50% brine and then suction filtered.  Afterwards it was observed that an abundance of 
unreacted Nile Blue A (12) was left in the solid, so the product was then triturated with EtOAc 
overnight.  The solution was then filtered and concentrated resulting in a sticky blue/purple 
material. 
After failure to obtain any product from experiments described in Table 3, the CDI 
coupling approach was abandoned.  The coupling reaction ran for over 168 h at an elevated 
temperature yielding no appreciable amount.  The failure of the coupling reaction was thought to 
be due to Nile Blue A (12) being a better leaving group than imidazole which was observed by 
LRMS.  Therefore, when vitamin D3 (1) added in to form the carbamate, Nile Blue A (12) would 
be displaced rather than the imidazole ring.  The CDI coupling was abandoned and alternate 
coupling reactions were investigated. 
3.1.5 Diisopropylcarbodiimide coupling 
Diisopropylcarbodiimide (DIC) is a peptide coupling reagent, and is used in conjunction 
with N-hydroxybenzotriazole  to form amide bonds
20.  The reaction conditions from Zhang and 
his associates21 were combined with the reaction conditions from Ho and his associates22 to 






















Scheme 12: DIC coupling between Nile Blue A (12) and Boc-Gly-OH (25) 
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Nile Blue A (12) was coupled with Boc-protected glycine (25) to form amide 26 (Scheme 
12).  Coupling to the glycine molecule allows the amine that is to be reacted with to be changed 
from an aromatic amine to an aliphatic amine.  This c ange allows for easier coupling of the 
amine.  Also, the DIC coupling reaction eliminates the flaws that the CDI coupling has such as 
having imidazole as a worse leaving group than NileBlue A (12).  The formation of amide 26 
was a relatively easy reaction, taking from 1 - 4 h and proceeding at room temperature.  Amide 26 
was readily precipitated out with saturated sodium bicarbonate and suction filtered.  The Boc 


















Scheme 13: Deprotection of Nile Blue A Boc-gly 26 by TFA 
The isolation of the deprotected Nile Blue A/glycine 27 has proven to be difficult.  The 
product was precipitated out of solution by diethyl ether but it only afforded an 8-9% yield.  The 
mass peak was observed via LRMS.  After Nile Blue A/glycine 27 was deprotected it was reacted 
with vitamin D3 imidazole 21 (3.0 eq.), and 27 (1.0 eq.) were dissolved in DMF (Scheme 14).  To 
that DMAP (1.0 eq.) and DIPEA (3.0 eq.) were added an the reaction was allowed to stir at rt for 
72 h.  Once 27 was seen to disappear by LRMS the reaction was dilute  in saturated NaHCO3 and 
suction filtered to yield carbamate 28.  The mass peak was never seen for carbamate 28 which 
may be due to the molecule’s size.  More work needs to be done with this system to fully 
synthesize carbamate 28 such as optimizing the formation of the deprotected amide 27, then 






























Scheme 14: Formation of carbamate 28 
With all of the problems that have been occurring for the coupling reactions, a different 
avenue needed to be investigated.  “Click” chemistry was studied as an alternate to the failing 
coupling reactions. 
3.1.6 “Click” chemistry coupling 
“Click” chemistry was first discovered by Ralph Huisgen as a reaction between a 
terminal alkyne and an azide.  These two functional groups react together in the presence of 
copper (I) to form a 1,2,3-triazole ring23.  The name “click” chemistry was then coined by Barry 
Sharpless due to the reaction’s progression at room temperature under aqueous conditions while 
being open to atmosphere, thus increasing the ease of th chemistry24. 
Before starting the “click” chemistry the linking functionality (minitags –alkyne and 
azide) must be coupled to our species.  An effectiv strategy was to use CDI coupling reactions 
from the previous section.  A model system was used again to optimize the conditions prior to 
testing the target system of vitamin D3 (1) and Nile Blue A (12).   
3.1.6.1 Model study of “click” chemistry 
The first step was to synthesize the terminal alkyne minitag on the model cyclohexanol as 











Scheme 15: CDI coupling to form model alkyne 
23 
This reaction was performed under the original conditions of KOH and toluene before being 
optimized with DMAP and DCM (Table 4).  The optimization involved fully converting 
cyclohexanol imidazole 20 to alkyne 30 resulting in increased yields of cyclohexanol alkyne 30.  
In entries 1-3 (Table 4) the ratio of cyclohexanol (13) to propargyl amine (29) was optimized.  It 
was found that 1 equivalent of 13 to every 1.5 equivalents of 29 was optimal. The final conditions 
of 1.0 eq. CDI, DCM and 0.05 eq. DMAP were carried over from the optimization of the 
formation of cyclohexanol imidazole 20 (Table 4, Entry 4). 











Entry Conditions Ratio (alcohol 13:amine 29) % Yielda % 20a 
1 CDI, toluene, KOH 2:1 19% 50% 
2 CDI, toluene, KOH 1:1 32% 22% 
3 CDI, toluene, KOH 1:1.5 30% 28% 
4 CDI, DCM, DMAP 1:1.5 54% 15% 
a Isolated yields 
Once cyclohexanol alkyne 30 was made, a one pot synthesis was carried out that formed 
















Scheme 16: Model system of one pot click reaction 
24 
This reaction yielded a 60% crude mass recovery.  The 1,2,3-triazole ring was observed using 1H 
NMR (Figure 14) and the mass peak was visualized with LRMS.   
  
Figure 14: 1H NMR (CDCl3) of cyclohexanol click product 31 with indicative 1,2,3-triazole peak 
Triazole 31 was never purified as confirmation of the reaction was the goal.  The CDI 
coupling to prepare  vitamin D3 alkyne 32 was undertaken by using the previously optimized 








































Entry Conditions Ratio (alcohol 1:amine 29) % Crude Yielda % 21 
1 CDI, toluene, KOH 1:1 80% (17%) 46% 
2 CDI, toluene, KOH 1:1.5 71-85% (32%) 41% 
3 CDI, DCM, DMAP 1:1.5 57-85% (40-51%) <1% 
a Isolated yield in ( ) 
As seen in Table 5, vitamin D3 imidazole intermediate 21 was formed along with vitamin D3 
alkyne 32. These reactions were performed to optimize the CDI coupling (Table 5).  The standard 
CDI coupling conditions of DCM and 0.05eq DMAP proved to be optimal based on isolated 
yields.  
Nile Blue A (12) and vitamin D3 alkyne 32 were attempted to be clicked together (Scheme 
17).  To accomplish this linking, an azide needed to functionalized onto Nile Blue A (12); in 
order to accomplish this 2.0 eq. Nile Blue A (12) was dissolved in 50% HCl (0.48mL) at 0°C and 
2.4 eq. of NaNO2 was added.  The resulting solution was stirred for 4 h.  Then a solution of 4 eq. 
NaN3 and 40 eq. NaOAc in 4.3mL of water was added dropwise. The solution was stirred for an 
additional 15 minutes before adding 0.41mL 7N NaOH, then 5.2mL of t-BuOH, 5.25 eq. Cu(s), 
1.3 eq. of CuSO4 and 1 eq. vitamin D3 alkyne 32. The mixture was allowed to stir at rt for 144 h.  
During the reaction, the disappearance of starting materials was observed by LRMS however no 
triazole 33 was seen.  The indicative 1,2,3-triazole peak (as in Figure 14) was not observed in the 
crude 1H NMR, therefore the one-pot click reaction was abandoned for approach A (linking 
26 
before ingestion).   Further discussions regarding the formation of the azide on Nile Blue A can 


























Scheme 17: One pot click coupling of 12 and 32 
A future direction for this reaction could be to run this again, but use 10 equivalents of Nile Blue 
A (12) to assure that enough of the azide is formed. 
3.2 Linking to the fluorophore after ingestion (approach B) 
The benefit of linking the fluorophore to vitamin D3 (1) after ingestion to the daphnia is 
the smaller size of the molecule being ingested by aphnia and polarity. The fluorophore attached 
to the vitamin D3 (1) may obstruct the second active site on vitamin D3 (1) which then would 
hinder the daphnia’s ability to utilize the compound the same as vitamin D3 (1).  In approach B 
(linking after ingestion) a minitag on vitamin D3 (1) and Nile Blue A (12) are created then the two 
are linked after ingestion of the daphnia.  The minitags are either a terminal alkyne or an azide, 
which will be used in subsequent click reactions 
There are three steps to approach B (linking after ingestion): forming minitagged vitamin 




























Scheme 18: Three steps for approach B (linking after ingestion) 
3.2.1 Synthesis of minitagged vitamin D3 (1) 
In click chemistry there are two functional groups that are necessary to form the 1,2,3-
triazole ring.  Both of these functional groups are going to function as minitags for the proposed 
approach B (linking after ingestion), as they are small additions to the larger molecule of vitamin 
D3 (1) or Nile Blue A (12).  The two minitags that need to be present are a terminal alkyne and an 
azide group. 
Propargyl amine (29), was linked onto vitamin D3 (1) to form vitamin D3 alkyne 32 using 
the optimized CDI reaction from approach A (linking before ingestion) (Table 5).  Then the azide 
minitag was synthesized on vitamin D3 (1), first with the model system.  These reactions were 
done so as to have vitamin D3 (1) linked with both possible minitags. 
28 
Azide 34 was synthesized using the conditions from Carboni, Benalil and Vaultier25 by 
stirring 9.75g of 3-chloropropyl amine hydrochloride (75 mmol, 1 eq.) with 14.64g of sodium 
azide (225 mmol, 3 eq.) in 225mL water for 18h at 80°C.  At the end of the reaction most of the 
water was removed by vacuum distillation, followed by addition of Et2O (300mL) and KOH 
(24g) pellets.  The aqueous layer was extracted with Et2O. The organics were washed with brine 
(120mL), dried over magnesium sulfate and concentrated to yield 6.46g of 3-azidopropan-1-
amine (34) (86% yield), which was used without purification. The reaction in Scheme 19 was run 
prior condition optimization with DCM and DMAP.  The reaction yielded 24-37% of 













Scheme 19: Formation of azide minitagged cyclohexanol 35 
When the KOH reaction conditions were extrapolated to the vitamin D3 (1) system a 
significant amount of vitamin D3 imidazole 21 was obtained (Table 6, Entry 1). 
As seen in Table 6, the yields of formation of azide 36 are less than that of the formation of 
vitamin D3 alkyne 32 (Table 5).  This may be a result of the instability of azide 36 compared to 
alkyne 32.  It was predicted that alkyne 32 would be an efficient alkyne coupling partner for the































Entry Conditions % yield 36 % 21 
1 CDI, toluene, KOH 51% 62% 
2 CDI, DCM, DMAP 63% (crude) NDa 
a Not detected by 1H NMR of crude product 
3.2.2 Synthesis of minitagged Nile Blue A (12) 
For “click” chemistry whichever minitag vitamin D3 (1) has linked to it, Nile Blue A (12) 
needs the corresponding minitag.  Seeing as the alkyne had higher yields, putting the azide on 
Nile Blue A (12) was focused on.  Nile Blue A (12) has an amine functionality and utilizing Hu 
and his associates’ reaction conditions it is possible to convert the amine group into an azide 
group26.  Using aniline as an example the standard conditions are as follows: to 560mg of anilne 
(6 mmol, 1.0 eq.) in a solution with 20mL 50% HCl at 0°C was added 497mg of NaNO3 (7.2 
mmol, 1.2 eq.).  The solution stirred for 3 h then 780mg of NaN3 (12 mmol, 2.0 eq.) and 9.84g 
NaOAc (120 mmol, 20 eq.) in 30mL of water was added ropwise over 15 minutes.  The reaction 
was extracted with EtOAc (3 x 25mL).  Combined organics were washed with brine (25mL), 
dried over magnesium sulfate and concentrated to yield 526mg of azidobenzene in a 74% yield 
(Scheme 20).  Using aniline was done to practice forming the azide and to use it as a model 








Scheme 20: Formation of azide 37 
With the use of 1H NMR, azide 37 was deemed pure enough to use in further reactions.   
Azide 37 was mixed with 1 equivalent of aniline (14) to prove that azide 37 was not contaminated 
with aniline (Figure 15).  In the aromatic region there are two distinct groups of aromatic peaks 
showing aniline (14) and the shifted aromatic peaks of azide 37. The reaction conditions above 
gave reasonable yields so it was then applied to Nile Blue A (12) (Scheme 21). 
 
Figure 15: 1H NMR (CDCl3) of a mixture of aniline (14) and azide 37 
The same reaction conditions as in Scheme 20 were us d on the Nile Blue A (12) system.  
Nile Blue A azide 38 was never successfully isolated.  It was seen to exist via LRMS, however 
the 1H NMR was a complex mixture.  Aromatic azides are known to be unstable and isolation has 
not been achieved thus far.  It was then thought that if Nile Blue A azide 38 was prepared it 
would be able to undergo the click reaction without being isolated in a one-pot two-step reaction 
















12 38  
Scheme 21: Formation of Nile Blue A azide 38 
In order to circumvent the problem of the aromatic zides decomposing a coupling 
between Nile Blue A (12) and azide 34 was undertaken.  Before this was done it was attempt d 
using the model system (Scheme 22). 
NH2









Scheme 22: CDI addition onto aniline (14) 
Aniline (14) (500mg, 5.4mmol, 1eq.) and 960mg of CDI (5.9mmol, 1.1eq.) were refluxed 
in 2.2mL DCM for 4 h.  The solution was diluted in 30mL DCM, washed with distilled water 
(3x12mL), brine (12mL), dried over magnesium sulfate nd concentrated to yield 962mg of 
aniline imidazole 39 (5.1 mmol, 95% yield)19.  The synthesis of aniline imidazole 39 was 
successful with a 95% crude yield. 
32 
 
Figure 16: 1H NMR of aniline imidazole 39 
The aniline imidazole 39 was observed via 1H NMR (Figure 16).  The imidazole peaks 
are hidden by the aromatic peaks, however one is observed at 7.16 ppm. One of the peaks 
downfield can be assigned as the amide proton on the structure.  Aniline imidazole 39 was 












Scheme 23: Formation of azide linked aniline 40 
Azide 40 was synthesized by refluxing 500mg of aniline imidazole 39 (2.7mmol, 1.0 eq.) 
and 267mg of azide 34 (2.7mmol, 1.0 eq.) in 1.0mL DCM for 4 h.  At the end of the reaction the 
mixture was diluted in 80mL Et2O, washed with 0.5N HCl (3x20mL), saturated sodium 
bicarbonate (20mL), brine (20mL), dried over magnesium sulfate, and concentrated.  The product 






EtOAc/hexanes) to yield 290mg of azide 40 (1.3 mmol, 49% yield).  Seeing as this reaction was

















Scheme 24: Formation of Nile Blue A azide 41 
Nile Blue A azide 41 was visualized via LRMS however the 1H NMR is a complex 
mixture, 7% mass recovery.  As has been previously stated (Section 3.1.4.1) CDI coupling with 
Nile Blue A (12) does not work, and this route was abandoned. 
3.2.3 “Click” chemistry 
Using Cu(I) catalyzed “click” chemistry will be an essential component to approach B 
(linking after ingestion).  Therefore, preparation and utilization of azides and alkyne compounds 
in developing a robust method to link the fluorophore and vitamin D3 (1) has been undertaken.  
“Click” reaction conditions vary based on which Cu(I) source they used, which can be seen by the 
examples of Scrafton and coworkers who uses CuI12 (Scheme 25) and Appukkuttan and 
coworkers who uses Cu(s)/CuSO4
27 (Scheme 26).  Nakamura and coworkers use CuSO4 and 















Scheme 25: Scrafton et. al. CuI reaction conditions12 
34 





81%46 43 47 48
 













Scheme 27: Nakamura et. al. CuSO4/Na ascorbate reaction conditions
28 
A comparison of the three conditions is summarized n Table 7 using the model system 
azide 35 and alkyne 30.  

















Entry Conditions Yield of 52a 
1 Cu, CuSO4, H2O/t-BuOH, rt, 18hr 68% 
2 CuI, DMSO, 80°C, 5hr 32% 
3 CuSO4, Na ascorbate, H2O/t-BuOH, rt, 18hr 9% 
a Isolated yield 
All sets of conditions yielded product. When utilizing Cu(s) and CuSO4 (Table 7, entry 1) 
a higher yield was obtained.  Therefore these reaction onditions were used in the majority of 
reactions.  It was not until later that the third condition was attempted (Table 7, entry 3).  It has a 
low yield however the product was mostly lost during purification and the reaction was never 
35 
repeated.  When running the click reaction using the Na ascorbate procedure, there was a very 
high crude yield with a very clear looking 1H NMR.  Crude azide 52 was then purified where the 
majority of the product degraded during column chromatography.  Due to the high purity of the 
crude product and the high yield of it, the Na ascorbate procedure was deemed the preferred 
procedure for future click reactions.   
A 1,2,3-triazole ring is easy to distinguish when looking at 1H NMR due to the singlet it 
produces at 7.6-8.0ppm from the single proton in the triazole ring (i.e. triazole 52 (Figure 17)). 
The 1,2,3-triazole peak was seen for triazole 52 so the reaction conditions (Table 7, entry 1) were 
applied to the vitamin D3 alkyne 32. 
 
Figure 17: 1H NMR (CDCl3) of triazole 52 using entry 3 conditions of Table 7 
The formation of vitamin D3 triazole 53 was attempted by dissolving 100mg of alkyne 32 
(0.2mmol, 1.0 eq.) in 0.6mL 1:1 t-BuOH:H2O, adding 50mg of azide 35 (0.2mmol, 1.0 eq.), 
11mg Cu(s) (0.17mmol, 0.8 eq.), 7mg CuSO4 (0.04mmol, 0.2 eq.), and stirring at rt for 20h 













filtered and separated.  The aqueous layer was extracted with Et2O (2x10mL).  The combined 
organic layers were washed with brine (6mL), dried over magnesium sulfate, and concentrated.  
Due to the lack of the 1,2,3-triazole peak around 8.0ppm in the 1H NMR (Figure 18), it was 

























Scheme 28: Click chemistry formation of vitamin D3 triazole 53 
 
Figure 18: 1H NMR (CDCl3) of crude vitamin D3 triazole 53 

































Scheme 29: Click chemistry formation of aniline triazole 54 
The click reaction was conducted under the same conditi s as the attempted synthesis of 53 
(Scheme 28), however it had higher crude yields of 47-59%.  The 1,2,3-triazole peak observed 
was indicative of aniline triazole 54 being produced.  There was no mass peak observed by 
LRMS, so the assumption that the peak at 7.73 was the 1,2,3-triazole peak could be wrong.  Peak 
A (Figure 19) also falls into the range of the exchangeable proton of a carbamate group.  
Therefore, it is inconclusive if aniline triazole 54 was synthesized.  The click reaction should be 
repeated using the Na ascorbate conditions for the formation of triazole 54 (Table 7, Entry 3). 
 












4. Future Directions 
Currently there are still aspects of this research that need to be further investigated.  The 
following sections will discuss how to further this work.  
4.1 Possible routes for approach A (linking before ingestion) 
There were difficulties in synthesizing a carbamate bond on Nile Blue A (12) using the 
CDI coupling method.  Other methods are left to be explored such as using reductive amination 
and Sonogashira coupling. 
The reductive amination can be used to link on an aldehyde that has an alkyne (or azide) 
on it to then have the product be clicked with the partnering vitamin D3 (1) minitag (Scheme 30).  
















Scheme 30: Proposed reductive amination method 
Another option is to brominate Nile Blue A (12), then perform a Sonogashira coupling to 




































Scheme 31: Proposed Sonogashira coupling method 
Lastly, in terms of the DIC coupling (Section 3.1.5) further work needs to be done to 
optimize the conditions of TFA deprotection reactions (Scheme 13).  Higher yields need to be 
obtained to keep DIC coupling a viable option. 
4.2 Possible routes for approach B (linking after ingestion) 
In addition to developing approach B (linking after ingestion) to address polarity and 
binding issues it is also important to have the wavelength change once the vitamin D3 (1) has 
been linked in vivo.  This change in wavelength is important so that it is possible to distinguish 
between linked fluorophore and unlinked fluorophore. Both minitags were synthesized on vitamin 
D3 (1), however an effective minitag on Nile Blue A (12) that is compatible with the aromatic 
ring has yet to be produced. 
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The DIC coupling can be used to fulfill the requirements for approach B (linking after 
ingestion).  If propiolic acid (59) was coupled to Nile Blue A (12) the conjugation can be 
















Scheme 32: Proposed DIC coupling for approach B (linking after ingestion) 
Conclusions 
A method of minitagging vitamin D3 (1) was described above.  Vitamin D3 (1) was 
functionalized with both an alkyne and an azide successfully while limiting the formation of 
intermediate imidazole compounds.  The functionalization of Nile Blue A (12) was described 
utilizing DIC coupling.  High percent recoveries were obtained with more work needed to be 
done on the deprotection of the Boc group.  “Click” hemistry was studied as is still a viable 
option for the in vivo coupling of vitamin D3 (1) and Nile Blue A (12).  Multiple avenues were 
discussed for future directions for this project such as Sonogashira coupling, reductive amination 
and further use of DIC coupling.  
41 
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General Experimental Procedure 
All reactions were stirred magnetically.  Reactions were heated in a sand bath encased in a 
heating mantel, controlling the temperature with a variable transformer.  Temperatures reported 
refer to bath temperatures unless otherwise noted.  Distillations were performed under argon 
atmosphere.  Vacuum distillations utilized a water spirator (> 15 mmHg). 
The phrase “concentrated” or “concentrated in vacuo” refers to removal of solvents via a rotary-
evaporator using a water aspirator. 
Reagents and Solvents 
All reagents and solvents were of commercial grade and were used as obtained from the suppliers 
except for the ones listed below that were purified as follows: 
Recrystallized copper iodide using the following procedure: 16g CuI was added to a boiling 
saturated solution of 50mL distilled H2O and 50g NaI.  The solution was boiled for 15 minutes.  
Then added 1g of decolorizing charcoal and boiled th  solution for an additional 15 minutes.  
Filtered and then diluted the cooled filtrate with 50mL H2O.  The resulting crystals were then 
filtered and washed with the following: water (10mL), ethanol (10mL), ethyl acetate (10mL), 
diethyl ether (10mL), and pentane (10mL).  The crystals were then dried overnight under vacuum 
from an oil pump and stored in a desiccator.   
Cyclohexanol was distilled under vacuum from CaO. 
Aniline was distilled under vacuum from CaH2. 
Chromatography 
“Chromatography” refers to flash column chromatography using 230-400 mesh silica gel (EMD 
Reagents).  Analytical and preparative thin layer chromatography (TLC) was performed on EMD 
pre-coated silica gel 60 F-254 plastic plates (0.25mm).  Visualization was performed by short 
wave UV light and/or staining the plate followed by heating with a heat gun for approximately 15 
seconds when appropriate.  P-anisaldehyde stain was prepared by mixing 15mL of p-
44 
anisaldehyde, 3mL glacial acetic acid, 10mL concentrated sulfuric acid, and 260mL of 95% 
ethanol. 
Physical Data and Instrumentation 
Proton Nuclear Magnetic Resonance (1H NMR) spectra were obtained on a Bruker DRX-300 
(300MHz) instrument.  Chemical shifts are reported in ppm downfield and are internally 
referenced using CDCl3 (7.26 ppm) or DMSO (2.50 ppm) as solvent.  Proton NMR data are 
reported as follows: chemical shift (multiplicity, coupling constants in Hz, number of protons).  
Multiplicity was abbreviated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), dd (doublet of a doublet), dt (doublet of a triplet), s (br) (broad singlet). 





























ylidene]ethylidene}-4-methylenecyclohexyl ester (21) 
To 211mg of CDI (1.3 mmol, 1.0 eq.) in 5.2 mL of DCM at 40°C under argon atmosphere and in 
the absence of light was added 8mg of DMAP (0.06 mmol, 0.05 eq.) and 500mg of vitamin D3
(1).  The solution was stirred for 3 h.  The reaction was monitored by silica gel TLC (Rf=0.49 
ethyl acetate/hexanes 1:1).  At the end of the reaction, the solution was allowed to cool to room 
temperature.  The organics were washed with water (2 x 5mL), and brine (5mL), dried over 
magnesium sulfate, filtered, and concentrated in vacuo to yield 493mg (1.0 mmol, 75% crude 
yield).  At times the crude product does require purification.  The crude product may be purified 
using silica gel column chromatography (5% EtOAc/hexanes  40% EtOAc/hexanes) 58% 
recovery of imidazole-1-carboxylic acid 3-{2-[1-(1,5-dimethylhexyl)-7a-methyloctahydroinden-
4-ylidene]ethylidene}-4-methylenecyclohexyl ester (21) as a yellow solid product. 
Compound 21 
Rf=0.49 (50% EtOAc/Hex) 
IR νmax (CHCl3)/cm
-1: 2949, 1751, 1394, 1278, 1238, 1001, 906, 729, 648 
1H NMR (300 MHz, CDCl3): δ 8.12 (s, 1H), 7.40 (s, 1H), 7.04 (s, 1H), 6.25 (d, J = 11.25 Hz, 
1H), 6.01 (d, J = 11.43, 1H), 5.19 (m, 1H), 5.10 (s, 1H), 4.88 (s, 1H), 2.81-2.65 (m, 2H), 2.58-
2.38 (m, 2H), 2.33-2.21 (m, 1H), 2.15-1.80 (m, 4H), 1.69-1.60 (m, 2H), 1.56-1.42 (m, 4H), 1.37-
1.22 (m, 4H), 1.14-1.08 (m, 2H), 0.90 (d, J = 6.06Hz, 3H), 0.84 (d, J = 6.57, 6H), 0.53 (s, 3H) 
47 
LRMS (ESI+): Exact mass calculated for C31H46N2O2[M+Na




















32 21  
Prop-2-ynylcarbamic acid 3-{2-[1-(1,5-dimethylhexyl)-7a-methyloctahydroinden-4-
ylidene]ethylidene}-4-methylenecyclohexyl ester (32) 
To 211mg of CDI (1.3 mmol, 1.0 eq.) in 5.2mL of DCM under argon atmosphere and in the 
absence of light was added 8mg of DMAP (0.06 mmol, 0.05 eq.) and 500mg of vitamin D3 (1).  
The solution was heated to 40°C and stirred for 4 h. T e reaction was monitored via silica gel 
TLC, when the reaction wasn’t seen to progress further added an additional 62mg of CDI (0.4 
mmol 0.3 eq.) was added.  The solution was stirred for 2 h more at 40°C.  Added 72mg of 
propargyl amine (29) (1.3 mmol, 1.0 eq.).  The solution was stirred for 18 h at 40°C.  At the end 
of the reaction the solution was allowed to cool to ro m temperature.  The reaction was diluted 
with DCM (15mL), washed with water (3 x 5mL), brine (5mL), dried over magnesium sulfate, 
filtered, and concentrated in vacuo.  The crude product was purified using silica gel column 
chromatography (5% EtOAc/hexanes  40% EtOAc/hexanes) to give 311mg (0.7mmol, 51% 
yield) of prop-2-ynyl-carbamic acid 3-{2-[1-(1,5-dimethylhexyl)-7a-methyloctahydroinden-4-
ylidene]ethylidene}-4-methylenecyclohexyl ester (32) as a yellow viscous product. 
Compound 32 
Rf= 0.88 (50% EtOAc/Hex) 
IR νmax (neat)/cm
-1: 3350, 2947, 2866, 1701, 1508, 1240, 1041, 906, 732, 655 
1H NMR (300MHz, CDCl3): δ 6.21 (d, J = 11.43, 1H), 6.02 (d, J = 10.95, 1H), 5.04, (s, 1H), 4.91 
(m, 1H), 4.83 (s, 1H), 3.97 (s, 2H), 2.84-2.75 (m, 1H), 2.62-2.53 (m, 1H), 2.42-2.31 (m, 2H), 
2.25-2.17 (m, 2H), 2.03 (s, 1H), 2.02-1.91 (m, 4H), 1.89-1.6s8 (m, 4H), 1.68-1.61 (m, 2H), 1.55-
49 
1.43 (m, 4H), 1.38-1.21 (m, 4H), 1.15-1.08 (m, 2H), 0.91 (d, J = 6.42Hz, 3H), 0.86 (d, J = 6.61, 
6H), 0.53 (s, 3H) 
LRMS (ESI+): Exact mass calculated for C31H47NO2[M+Na

























ylidene]ethylidene}-4-methylenecyclohexyl ester (36) 
To 250mg of 21 (0.52 mmol, 1.0 eq.) in 0.5mL DCM under argon atmosphere was added 78mg 
of 34 (0.78mmol, 1.5 eq.).  The solution was stirred for 4 h at 40°C.  The reaction was monitored 
via silica gel TLC.  Upon the completion of the reaction, the solution was cooled to rt, diluted in 
diethyl ether (80mL), washed with 0.5N HCl (3x 20mL), saturated sodium bicarbonate solution 
(20mL), brine (20mL), dried over magnesium sulfate, filtered, and concentrated in vacuo.  The 
crude product was purified using silica gel column chromatography (5% EtOAc/hexanes  30% 
EtOAc/hexanes) to give 96mg (0.18mmol, 36% yield) of (3-azidopropyl)-carbamic acid 3-{2-[1-
(1,5-dimethylhexyl)-7a-methyloctahydroinden-4-ylidene]ethylidene}-4-methylenecyclohexyl 
ester (36) as a yellow viscous product. 
Compound 36 
Rf= 0.92 (50% EtOAc/Hex) 
IR νmax (neat)/cm
-1: 3490, 2645, 2866, 2094, 1701, 1516, 1238, 906, 731 
1H NMR (300MHz, CDCl3): δ 6.22 (d, J = 10.98, 1H), 6.03 (d, J = 10.98, 1H), 5.05 (s, 1H), 4.86 
(m, 1H), 4.83 (s, 1H), 3.36 (t, J = 6.18, 2H), 3.26 (q, J = 6.18, 2H), 2.85-2.76 (m, 1H), 2.61-2.53 
(m, 1H), 2.43-2.31 (m, 2H), 2.26-2.12 (m, 2H), 2.00-1.57 (m, 2H), 1.57-1.41 (m, 1H), 1.38-1.25 
(m, 15H), 1.17-1.07 (m, 2H), 0.96 (d, J = 6.54, 2H), 0.91 (d, J = 12.78, 3H), 0.86 (d, J = 7.32, 
6H), 0.54 (s, 3H) 
LRMS (ESI+): Exact mass calculated for C31H50N4O2[M+Na
























To 294mg of Nile Blue A (12) (0.8 mmol, 1 eq.) in 6mL DMF was added 198mg DIC (1.6 mmol, 
2 eq.), 240mg HOBt*H2O (1.6 mmol, 2 eq.), 96mg DMAP (0.8 mmol, 1 eq.), 304mg DIPEA (2.4 
mmol, 3 eq.), 413 mg Boc-Gly-OH (25) (2.4 mmol, 3 eq.).  The solution stirred for 2 h at rt.  The 
reaction was monitored via LRMS. After 2 h added 198mg DIC (1.6 mmol, 2 eq.), 240 mg 
HOBt*H2O (1.6 mmol, 2 eq.), 202mg DIPEA (1.6 mmol, 2 eq.), 275mg Boc-Gly-OH (1.6 mmol, 
2 eq.).   The solution stirred for an additional 1 h at which point the reaction had been deemed 
completed via LRMS.  The product was precipitated out from 12mL saturated sodium 
bicarbonate and filtered.  Rinsed solid with 10mL saturated sodium bicarbonate to yield a wet 
blue solid.  It was dried under hi-vac for 1 hour to yield 320 mg (0.6mmol, 86% yield) of [5-(2-
tert-butoxycarbonylaminoacetylamino)benzo[a]phenoxazin-0-ylidene]diethylammonium (26) as 




-1: 3338, 2966, 1614, 1246, 1165, 831, 694 
1H NMR (300MHz, CDCl3): δ 8.55 (d, J = 6.96, 1H), 8.26 (d, J = 8.1, 1H), 7.79 (t, J = 7.59, 1H), 
7.70 (t, J = 7.65, 1H), 7.58 (d, J = 8.64, 1H), 7.19 (t, J = 5.79, 1H), 6.80 (dd, J = 8.94, J = 2.25, 
1H), 6.63 (ds, J = 2.61, 1H), 6.38 (s, 1H), 5.48 ( d, J = 7.65, 18H), 3.85 ( d, J = 6.12, 2H), 3.63 
(m, 22H), 3.50 (q, J = 6.45, 6H), 3.31 (s, 40H), 1.37 (s, 8H), 1.14 (d, J = 6.36, 11H),  
LRMS (ESI+): Exact mass calculated for C31H50N4O2 = 475.23, found = 475.3 
52 
Appendix 
The following pages contain 1H NMR, and IR spectra for certain compounds.  The structures and 
numbers of the structures are located with each spectrum. 





























1a,25-Dihydroxyvitamin D3 (5)  
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CDI, 0.05 equiv DMAP
DMF




































 DCM, reflux, 3hr
75% crude yield
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13 34 35 20
CDI, KOH
toluene, 16-37%



















12 38  
Scheme 21: Formation of Nile Blue A azide 38 
NH2





















































Scheme 25: Scrafton et. al. CuI reaction conditions 
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Scheme 32: Proposed DIC coupling for approach B (linking after ingestion) 
62 
O
H
H
N
O
N
21
63 
O
H
H
N
O
N
21
64 
O
H
H
NH
O
32
65 
O
H
H
NH
O
32
66 
O
H
H
NH
O
N3
36
67 
O
H
H
NH
O
N3
36
68 
 
N
ON
+
NH
O
NH
O
O
26
69 
 
  
N
ON
+
NH
O
NH
O
O
26
70 
 
